Patents by Inventor Klaus Döhler

Klaus Döhler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160207970
    Abstract: A peptide of the formula R1—NH-HAEGTFTSDVSSYLEGQAAKEFIAWLVK-CONR2R3 wherein R?H or an organic compound comprising from 1 to 10 carbon atoms and R2R3=independently H or an alkyl group of 1 to 4 carbon atoms; can be used for the treatment and prophylaxis of heart ischemia-reperfusion injury.
    Type: Application
    Filed: April 1, 2016
    Publication date: July 21, 2016
    Inventors: Marek Treiman, Henrik K. Salling, Klaus Döhler, Thomas Engstrom
  • Publication number: 20140336118
    Abstract: A peptide of the formula R1-NH-HAEGTFTSDVSSYLEGQAAKEFIAWLVK-CONR2R3 wherein R=H or an organic compound comprising from 1 to 10 carbon atoms and R2 R3=independently H or an alkyl group of 1 to 4 carbon atoms; or certain analogues of said GLP-1 peptide can be used for the treatment and prophylaxis of heart ischemia-reperfusion injury
    Type: Application
    Filed: October 29, 2012
    Publication date: November 13, 2014
    Inventors: Marek Treiman, Henrik K. Salling, Klaus Döhler, Thomas Engstrøm
  • Patent number: 7732406
    Abstract: The present invention relates to the use of a natriurectic peptide, such as urodilatin, for treating a patient suffering from heart failure, such as acute decompensated heart failure. Preferably, a composition comprising an effective amount of urodilatin is intravenously administered to the patient continuously through a time period of at least 24 hours and up to 120 hours, preferably at least 48 hours.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: June 8, 2010
    Assignee: CardioPep Pharma GmbH
    Inventors: Veselin Mitrovic, Hartmut Lüss, Wolf-Georg Forssmann, Markus Meyer, Klaus Döhler